Vetoquinol (VETO)

Currency in EUR
80.40
-0.50(-0.62%)
Real-time Data·
Earnings results expected in 5 days
VETO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
80.0080.90
52 wk Range
68.7091.50
Key Statistics
Prev. Close
80.9
Open
80.9
Day's Range
80-80.9
52 wk Range
68.7-91.5
Volume
509
Average Volume (3m)
2.37K
1-Year Change
6.7282%
Book Value / Share
48.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VETO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
89.30
Upside
+11.07%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 19 consecutive years

Vetoquinol News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Employees
2497
Market
France

Compare VETO to Peers and Sector

Metrics to compare
VETO
Peers
Sector
Relationship
P/E Ratio
16.7x18.5x−0.5x
PEG Ratio
-0.740.00
Price/Book
1.7x3.0x2.6x
Price / LTM Sales
1.8x2.7x3.2x
Upside (Analyst Target)
5.6%8.1%45.2%
Fair Value Upside
Unlock6.3%6.4%Unlock

Analyst Ratings

2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 89.30
(+11.07% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
1.08%
Industry Median 4.82%
Annualised payout
0.89
Paid annually
5-Years Growth
+13.21%
Growth Streak

Earnings

Latest Release
27/03/2026
EPS / Forecast
-- / --
Revenue / Forecast
141.5M / --
EPS Revisions
Last 90 days

People Also Watch

358.00
IDLA
+6.55%
33.60
SWOR
-0.44%
37.70
NRO
+0.67%
0.3705
ALSEN
-2.88%
40.45
EQSE
-1.22%

FAQ

What Is the Vetoquinol (Paris: VETO) Share Price Today?

The Vetoquinol stock price today is 80.40 EUR.

What Stock Exchange Does Vetoquinol (VETO) Trade On?

Vetoquinol is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Vetoquinol?

The stock symbol (also called a 'ticker') for Vetoquinol is "VETO."

Does Vetoquinol Pay Dividends? What’s The Current VETO Dividend Yield?

Yes, VETO Pays Dividends to its Shareholders. The current Vetoquinol dividend yield is 1.08%.

What Is the Current Vetoquinol Market Capitalisation?

As of today, Vetoquinol (Paris: VETO) market cap is 949.55M EUR.

When Is the Next Vetoquinol Earnings Date?

Vetoquinol's next earnings report will be released on 28/04/2026.

Is VETO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Vetoquinol moving averages and other technical indicators, the daily buy/sell signal for VETO stock is Sell.

How Many Times Has Vetoquinol Stock Split?

Vetoquinol has split 0 times. (See the VETO stock split history page for full effective split date and price information.)

How Many Employees Does Vetoquinol Have?

Vetoquinol has 2497 employees, based on their latest Companies House report.

What is the current trading status of Vetoquinol (Paris: VETO)?

As of 23/04/2026, Vetoquinol (VETO) is trading at a share price of 80.40 EUR, with a previous close of 80.90 EUR. The stock has fluctuated within a day range of 80.00 EUR to 80.90 EUR, while its 52-week range spans from 68.70 EUR to 91.50 EUR.

What Is Vetoquinol (VETO) Price Target According to Analysts?

The average 12-month price target for Vetoquinol is 89.30 EUR, with a high estimate of 110 EUR and a low estimate of 80 EUR. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +11.07% Upside potential.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.